UPC_CFI_191/2025; UPC_CFI_192/2025 – Genevant v Moderna
- Court
- Local Division The Hague
- Date
- Outcome
- Granted
- Sector
- Other
- Decision Type
- PROCEDURAL
Expert Commentary
Background The JR has decided on Moderna’s Preliminary Objection. Moderna requests review and in the alternative also leave for appeal against the decision of the panel. The JR The JR gives the claimants one week to react. Comment Publication of these types of orders does not add much, except that it shows that the Local Division of The Hague takes the speed of the proceedings seriously.
Full Decision Text
1 The Hague - Local Division UPC_CFI_191/2025 and 192/2025 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 12/06/2025 APPLICANT/S – DEFENDANTS IN THE MAIN PROCEEDINGSIN THE MAIN PROCEEDINGS 1) Moderna, Inc. (Applicant) - 325 Binney Street - MA 02142 - Cambridge - US Represented by Ruben Laddé 2) Moderna Belgium S.R.L. (Applicant) - Avenue Marnix 23 - 1000 - Brussels - BE Represented by Ruben Laddé 3) Moderna Denmark ApS (Applicant) - C/O CSC (DENMARK) ApS Sundkrogsgade 21 - 2100 - Copenhagen - DK Represented by Ruben Laddé 4) Moderna Sweden AB (Applicant) - c/o Scandinavian Trust AB, Birger Jarlsgatan 12 - 114 34 - Stockholm - SE Represented by Ruben Laddé 5) Moderna Switzerland GmbH (Applicant) - Peter Merian-Weg 10 - 4052 - Basel - CH Represented by Joachim Renken 2 6) Moderna Portugal Unipessoal LDA (Applicant) - Rua João Chagas 10-B DTO - 1500-493 - Lisbon - PT Represented by Ruben Laddé 7) ModernaTX, Inc. (Applicant) - 325 Binney Street - MA 02142 - Cambridge - US Represented by Ruben Laddé 8) Moderna Norway AS (Applicant) - c/o CSC (Norway) AS, Wergelandsveien 7 - 0167 - Oslo - NO Represented by Ruben Laddé 9) Moderna Poland SP. Z.O.O. (Applicant) - Rondo Ignacego Daszyńskiego 1 - 00-843 - Warsaw - PL Represented by Ruben Laddé 10) Moderna Netherlands B.V. (Applicant) - Claude Debussylaan 7 - 1082 MC - Amsterdam - NL Represented by Ruben Laddé 11) Moderna Biotech UK Limited (Applicant) - 54 Portland Place - W1B 1DY - London - GB Represented by Ruben Laddé 12) Moderna Italy S.R.L. (Applicant) - Via Vittorio Veneto 54/B - CAP 00187 - Rome - IT Represented by Ruben Laddé 3 13) Moderna Biotech Spain SL (Applicant) - C/ Julián Camarillo 31 - 28037 - Madrid - ES Represented by Ruben Laddé 14) Moderna France SASU (Applicant) - 19 Rue Cognacq-Jay - 75007 - Paris - FR Represented by Ruben Laddé 15) Moderna Germany GmbH (Applicant) - Brienner Straße 45 a-d. c/o Design Offices Campus Königsplatz - 80333 - Munich - DE Represented by Ruben Laddé Applicants/Defendants 1 to 15, defendants in the main proceedings are hereinafter referred to as “Defendants”. RELEVANT PROCEEDING PARTIES – CLAIMANTS IN THE MAIN PROCEEDINGS 1) Genevant Sciences GmbH (Main proceeding party - Claimant) - Viaduktstrasse 8 - 4051 - Basel - CH Represented by Markus Van Gardingen 2) Arbutus Biopharma Corporation (Main proceeding party - Claimant) - 701 Veterans Circle - PA 18974 - Warminster – US Claimants in the main proceedings are hereinafter collectively called: “Claimants” Represented by Markus Van Gardingen PATENTS AT ISSUE 4 Patent no. Proprietor/s EP2279254 EP4241767 Arbutus Biopharma Corporation (in case 191/2025) Arbutus Biopharma Corporation (in case 192/2025) DECIDING JUDGE Judge-rapporteur (JR) LANGUAGE OF PROCEEDINGS: English BACKGROUND AND ORDER SOUGHT BY THE PARTIES 1. Defendants filed an ‘application to review a case management order’ (R. 333 RoP), as App_27016/2025, requesting to have the order of the JR of 23 May 2025 (ORD 21852/2025) regarding preliminary objections filed by Defendants, reviewed by the entire panel (Rule 333.1 RoP). In the alternative to allow the appeal against the decision of the panel on the preliminary objections. 2. The order concerns four separately filed preliminary objections (the “POs”, filed as App_19208/2025, App_19773/2025, App_19158/2025 and App_19821/202) in two infringement actions (UPC_CFI_191/2025 and UPC_CFI_192) pending between Claimants and Defendants. ORDER Claimants are given the opportunity to respond within one week. ORDER DETAILS Order no. ORD_28166/2025 in ACTION NUMBERS: ACT_10280/2025 and ACT_10284/2025 UPC numbers: UPC_CFI_191/2025 and UPC_CFI_192/2025 (respectively) Action type: Infringement Actions Related proceeding no. Application No.: 27016/2025 Application Type: APPLICATION_ROP_333
Key Holdings
- Short deadline (one week) set for reaction to review request.
- Emphasis on speed of proceedings.
Tags
- Case Management
- Preliminary Injunction
- Review
- Time Limits
Related Cases
- UPC_CFI_251/2025; UPC_CFI_769/2025 – Maxell v Samsung
- UPC_CFI_499/2024 – Amycell v X
- UPC CFI 455/2024 – City Glass and Glazing Private Limited v Maars Holding B.V. et al.
- UPC CFI 327/2024 – Winnow Solutions Limited v Orbisk B.V.
- UPC CFI 187/2024 and UPC CFI 507/2024 – Advanced Cell Diagnostics, Inc. v Molecular Instruments, Inc.